In a new step that gives hope to the world’s battle against the emerging coronavirus, British scientists started on Tuesday resorting to an experimental drug and a simple technique for treating patients with early cases of “Covid 19” as soon as symptoms appear on them.
This technique relies on delivering a drug to the lungs through the "inhaler" spray, shortly after the patient's symptoms appear, before entering into serious complications.
According to the British newspaper "Sun", researchers from the University of Southampton sent 120 sprays to "Covid 19" patients to conduct experiments in their homes from Tuesday.
The technology known to patients with respiratory diseases uses an experimental drug that boosts the immune system, and contains a protein called "interferon beta", which is usually produced by the human body when infected with a viral infection.
This protein is already being used in the treatment of multiple sclerosis patients, and it has previously shown promising results in relieving symptoms of "Covid 19" disease caused by the emerging coronavirus , through experiments in Hong Kong, where it was combined with other drugs.
In the usual way, the patient inhales the medication in order to reach the lungs directly, which may protect the injured from entering the "fatal phase" whose symptoms usually appear after the tenth day after the onset of symptoms .
In the experiment, patients will receive one "breath" from the inhaler once a day, while doctors record changes in the saturation of the lungs with oxygen and the temperature of the patients.
The follow-up device will then monitor the patient's condition for 14 days to ensure that they have not relapsed.
If the clinical trials are successful, the Southampton-based company, CineArgin, hopes to roll out millions of doses later this year, which will be a qualitative step in the face of the frightening pandemic .
The inhaler team will soon complete the treatment experience in a hospital of 100 patients, and the results will be published in July, but they confirm that the final word on the efficacy of the new drug will be for home tests.
"We need treatment that can be given to patients early in the course of the disease, in order to prevent progression to severe symptoms," study head Professor Nick Francis told the Daily Mail.
Corona patients usually enter the risk stages during the second week of infection, including breathing problems that may amount to pneumonia.
It is the new drug that can prevent the virus from entering the "fatal week," said Richard Marsden, president of "CineArgin," and added: "We can prevent people from the second bad week."
"This was the pattern. It was about the tenth day when people are facing major problems. They are transmitting symptoms that are similar to symptoms," Marsden said. Influenza to very difficult breathing and pneumonia ."
Post a Comment